AKT1 and glioblastoma: Other examples of defining fusions are SLC3A2-NRG1 (in which chimeric protein activates AKT and ERK pathways) in invasive mucinous adenocarcinoma of the lung (27%) [93], and EGFR-SEPT14 fusion gene in glioblastoma [94].